切莱利思林抑制NR2B NMDA受体,独立于PKC活动
Jie Hao1, Xia Qin1, LiZhao Guan2
1Department of Pharmacology of Chinese Materia Medica, Institution of Chinese Integrative Medicine, Hebei Medical University, Research Unit of Digestive Tract Microecosystem Pharmacology and Toxicology, Chinese Academy of Medical Sciences, Shijiazhuang, Hebei, 050017, China.
切莱利思林 (CHE) 抑制N-甲基-d-阿斯巴酸盐受体 (NMDARs),对大脑功能和神经系统疾病至关重要. 这项研究揭示了CHE.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- N-甲基-d-酸盐受体 (NMDARs) 是中枢神经系统 (CNS) 中的主要刺激性神经传递介质.
- NMDARs涉及神经系统疾病,如缺血症,痴呆症和疼痛,呈现治疗点.
- 切莱里 (CHE) 是一种天然类化合物,表现出各种生物活性,但其对NMDARs的作用机制尚不清楚.
研究的目的:
- 调查切利利 (CHE) 对N-甲基-d-酸盐受体 (NMDARs) 的作用.
- 阐明CHE与NMDARs相互作用的潜在分子机制,特别是GluN2B子单元.
主要方法:
- 用初级培养的皮质神经元来评估NMDA诱导的电流.
- 用HEK293T细胞来表达NMDAR用于机理学研究.
- 进行了分子对接和突变发生分析,以确定相互作用部位.
主要成果:
- 在皮层神经元中,CHE显著抑制了NMDA诱导的电流.
- CHE及其类似物抑制了NMDAR电流,并加速了HEK293T细胞中的GluN2BNMDAR脱敏.
- 抑制独立于蛋白质激酶C活性,并显示pH依赖性,表明在GluN2BThr647附近的M3α螺旋段的直接相互作用.
结论:
- 切莱里思林 (CHE) 直接抑制NMDAR功能,并促进GluN2B介导的脱敏.
- CHE的行动涉及阻塞NMDAR通道孔区域.
- 这项研究揭示了NMDARs上CHE的新型抑制机制,这与神经系统疾病治疗相关.
相关概念视频
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Drugs Affecting Neurotransmitter Release or Uptake
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists


